Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Experimental and Therapeutic Medicine|June 8, 2026
Fatty acid-activated proton transporter SR4 prevents hepatic steatosis and metabolic alterations in diabetic mice by improving mitochondria function, energy balance and oxidative stressJames Figarola, Jyotsana Singhal, Sharad SinghalSeminars in Cancer Biology|July 5, 2022
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeuticsSaumya Srivastava, Atish Mohanty, Arin Nam, et al.Oncotarget|January 18, 2019
Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomasJames L Figarola, Jyotsana Singhal, Sharad Singhal, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 11, 2013
Improving prediction of surgery duration using operational and temporal factorsEnis Kayis, Haiyan Wang, Meghna Patel, et al.Biomolecules|November 25, 2023
A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung CancerPrakash Kulkarni, Atish Mohanty, Sravani Ramisetty, et al.International Journal of Oncology|April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell linesTamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.Iscience|August 9, 2023
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitorsLinlin Guo, Atish Mohanty, Sharad Singhal, et al.Journal of Clinical Medicine|October 14, 2022
Addressing Drug Resistance in Cancer: A Team Medicine ApproachPrakash Kulkarni, Atish Mohanty, Supriyo Bhattacharya, et al.Pageof 1